{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T09:51:09Z","timestamp":1774777869854,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.reprotox.2010.11.012","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T05:49:37Z","timestamp":1291096177000},"page":"375-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Potency ranking of valproic acid analogues as to inhibition of cardiac differentiation of embryonic stem cells in comparison to their in vivo embryotoxicity"],"prefix":"10.1016","volume":"31","author":[{"given":"E.","family":"de Jong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.C.M.","family":"Doed\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Reis-Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Nau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.H.","family":"Piersma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2010.11.012_bib0005","article-title":"Alternative approaches can reduce the use of test animals under REACH","author":"Van der Jagt","year":"2004","journal-title":"Report EUR 21405"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/026119290403200305","article-title":"Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests","volume":"32","author":"Genschow","year":"2004","journal-title":"Altern Lab Anim"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/026119290403200307","article-title":"Validation of the postimplantation rat whole-embryo culture test in the international ECVAM validation study on three in vitro embryotoxicity tests","volume":"32","author":"Piersma","year":"2004","journal-title":"Altern Lab Anim"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/bdrb.20223","article-title":"Development of a zebrafish embryo teratogenicity assay and quantitative prediction model","volume":"89","author":"Brannen","year":"2010","journal-title":"Birth Defects Res B: Dev Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/026119290403200503","article-title":"A modular approach to the ECVAM principles on test validity","volume":"32","author":"Hartung","year":"2004","journal-title":"Altern Lab Anim"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0030","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/026119290603400504","article-title":"The practical application of three validated in vitro embryotoxicity tests. The report and recommendations of an ECVAM\/ZEBET workshop (ECVAM workshop 57)","volume":"34","author":"Spielmann","year":"2006","journal-title":"Altern Lab Anim"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1742-7843.2006.pto_373.x","article-title":"Alternative methods for developmental toxicity testing","volume":"98","author":"Piersma","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0040","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/10408440600894914","article-title":"A category approach for reproductive effects of phthalates","volume":"36","author":"Fabjan","year":"2006","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.reprotox.2009.12.003","article-title":"Integrating (Q)SAR models, expert systems and read-across approaches for the prediction of developmental toxicity","volume":"30","author":"Hewitt","year":"2010","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","article-title":"Valproic acid in pregnancy: how much are we endangering the embryo and fetus?","volume":"28","author":"Ornoy","year":"2009","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1684\/j.1950-6945.2004.tb00053.x","article-title":"Antiepileptic drugs: indications other than epilepsy","volume":"6","author":"Spina","year":"2004","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0060","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/0272-0590(86)90179-X","article-title":"Valproic acid teratogenicity in mice after various administration and phenobarbital-pretreatment regimens: the parent drug and not one of the metabolites assayed is implicated as teratogen","volume":"6","author":"Nau","year":"1986","journal-title":"Fundam Appl Toxicol"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0065","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1600-0773.1991.tb01303.x","article-title":"Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms","volume":"69","author":"Nau","year":"1991","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0070","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0272-0590(88)90112-1","article-title":"Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague\u2013Dawley rats","volume":"11","author":"Binkerd","year":"1988","journal-title":"Fundam Appl Toxicol"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0075","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1517\/14740338.4.2.345","article-title":"Teratogenicity of sodium valproate","volume":"4","author":"Alsdorf","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0080","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(82)90018-6","article-title":"Valproic acid and spina bifida","volume":"320","author":"Bjerkedal","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0085","first-page":"119","article-title":"The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort","volume":"42","author":"Omtzigt","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0090","article-title":"Major malformations with valproic acid","volume":"52","author":"Koren","year":"2006","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0095","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1021\/tx950216s","article-title":"Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect","volume":"9","author":"Bojic","year":"1996","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0100","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1021\/tx0502241","article-title":"Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives","volume":"19","author":"Eikel","year":"2006","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0378-4274(92)90269-P","article-title":"The enantioselective teratogenicity of 2-n-propyl-4-pentynoic acid (4-yn-VPA) is due to stereoselective intrinsic activity and not differences in pharmacokinetics","volume":"60","author":"Hauck","year":"1992","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/toxsci\/kfp083","article-title":"Relative developmental toxicity of glycol ether alkoxy acid metabolites in the embryonic stem cell test as compared with the in vivo potency of their parent compounds","volume":"110","author":"de Jong","year":"2009","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0115","doi-asserted-by":"crossref","DOI":"10.1093\/toxsci\/kfq270","article-title":"The use of in vitro toxicity data and physiologically based kinetic modeling to predict dose\u2013response curves for in vivo developmental toxicity of glycol ethers in rat and man","author":"Louisse","year":"2010","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0120","doi-asserted-by":"crossref","first-page":"9222","DOI":"10.1128\/MCB.23.24.9222-9232.2003","article-title":"Myocardin expression is regulated by Nkx2.5, and its function is required for cardiomyogenesis","volume":"23","author":"Ueyama","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0125","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1006\/jmcc.1996.0112","article-title":"Alpha-myosin heavy chain gene regulation: delineation and characterization of the cardiac muscle-specific enhancer and muscle-specific promoter","volume":"28","author":"Molkentin","year":"1996","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0130","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0008-6363(03)00248-7","article-title":"Cardiac specific differentiation of mouse embryonic stem cells","volume":"58","author":"Sachinidis","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0135","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/toxsci\/66.2.298","article-title":"Dose\u2013response modeling of continuous endpoints","volume":"66","author":"Slob","year":"2002","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0140","first-page":"1","article-title":"Guidance of the scientific committee on a request from EFSA on the use of the benchmark dose approach in risk assessment","volume":"1150","author":"EFSA","year":"2009","journal-title":"EFSA J"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0145","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/toxsci\/kfi144","article-title":"A comparison of ratio distributions based on the NOAEL and the benchmark approach for subchronic-to-chronic extrapolation","volume":"85","author":"Bokkers","year":"2005","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0150","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/0024-3205(81)90541-5","article-title":"A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations","volume":"29","author":"Nau","year":"1981","journal-title":"Life Sci"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0155","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.tiv.2003.09.007","article-title":"Monitoring of teratogenic effects in vitro by analysing a selected gene expression pattern","volume":"18","author":"Pellizzer","year":"2004","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0160","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0887-2333(01)00071-6","article-title":"Molecular markers in embryonic stem cells","volume":"15","author":"zur Nieden","year":"2001","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0165","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0887-2333(01)00007-8","article-title":"Establishment of an in vitro reporter gene assay for developmental cardiac toxicity","volume":"15","author":"Bremer","year":"2001","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-213X-9-5","article-title":"Gene expression profiles during early differentiation of mouse embryonic stem cells","volume":"9","author":"Mansergh","year":"2009","journal-title":"BMC Dev Biol"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0175","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.reprotox.2003.10.015","article-title":"Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test","volume":"18","author":"Seiler","year":"2004","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0180","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1152\/physrev.00054.2003","article-title":"Embryonic stem cells: prospects for developmental biology and cell therapy","volume":"85","author":"Wobus","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0185","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1023\/A:1015832411981","article-title":"The enantiomers of the valproic acid analogue 2-n-propyl-4-pentynoic acid (4-yn-VPA): asymmetric synthesis and highly stereoselective teratogenicity in mice","volume":"9","author":"Hauck","year":"1992","journal-title":"Pharm Res"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0190","article-title":"ReProGlo: a new stem cell-based reporter assay aimed to predict embryotoxic potential of drugs and chemicals","author":"Uibel","year":"2009","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0195","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.reprotox.2010.11.012_bib0200","series-title":"Embryotoxizit\u00e4t, antikonvulsive wirkung, sedierung und adipogenese: Struktur-aktivit\u00e4ts-studien von valproins\u00e4ure-derivataten bei der maus und in C3H\/10T1\/2-zellen. Dissertation","author":"Volland","year":"2002"}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623810003503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623810003503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:31:42Z","timestamp":1760189502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623810003503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0890623810003503"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2010.11.012","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potency ranking of valproic acid analogues as to inhibition of cardiac differentiation of embryonic stem cells in comparison to their in vivo embryotoxicity","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2010.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}